On Monday, Calumet (CLMT.US) surged significantly, rising nearly 7% to $21.44.
According to the WiseFinance APP, on Monday, Calumet (CLMT.US) surged significantly, rising nearly 7% to $21.44. On the news front, analyst Roger Read from Fulcrum Group maintains a "buy" rating for Calumet and raises the target price from $25 to $29.